By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Corbus Pharmaceuticals, Inc.  

100 River Ridge Drive

Norwood  Massachusetts  02062   U.S.A.
Phone: 617-963-0100 Fax: 617-663-6085



Company News
The Hype Behind Massachusetts Biotech Corbus (CRBP)' Sole Pipeline Drug 3/17/2017 6:34:20 AM
Corbus (CRBP) To Present Gene Expression Data From Recent Phase II Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation And Fibrosis Pathways 3/8/2017 10:11:03 AM
Corbus (CRBP) Announces $27.2 Million Registered Direct Offering 2/28/2017 1:43:34 PM
Corbus (CRBP) Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation In Alveolar Macrophages From Cystic Fibrosis Patients 2/24/2017 12:17:01 PM
Corbus (CRBP) Release: Pharma Receives Orphan Designation For JBT-101 For The Treatment Of Systemic Sclerosis In The European Union 1/17/2017 11:39:16 AM
Why Corbus (CRBP)' Stock Rocketed 412% Upwards in 2016 1/17/2017 8:49:07 AM
Why Massachusetts’ Corbus (CRBP) Keeps a ‘Remarkably Young Staff’—And How it Plans to Double Headcount 12/8/2016 6:30:43 AM
Corbus (CRBP) To Ring The Nasdaq Stock Market Closing Bell 12/6/2016 7:25:42 AM
Little Corbus (CRBP) Gains Close to $180 Million in Market Cap on Mid-Stage Systemic Sclerosis Data 11/14/2016 6:25:29 AM
Unnamed Fund Manager With Reliable Track Record Says High-Flying Corbus (CRBP) is About to Crash 10/25/2016 6:59:33 AM